MDx Medical hit its mark with $19.6 million raised in a series C funding round that was slated to expire in 2015. The company roped in the cash through equity financing and series C preferred stock, backed by 15 unnamed investors.
In SEC filings MDx Medical reported that a portion of the funding will go towards corporate salaries, but the company didn’t identify an amount.
